Review article: Improving drug safety for patients undergoing anesthesia and surgery

Canadian Journal of Anesthesia

Volumn 60, Issue 2, 2013, Pages 127-135

  Orser, Beverley A ^a   Hyland, Sylvia ^b   David, U ^b   Sheppard, Ian ^b   Wilson, C Ruth ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Institut pour l'utilisation securitaire des medicaments du Canada   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ACCURACY; ADVERSE OUTCOME; AMPOULE; ANESTHESIA INDUCTION; AUTOMATION; CLINICAL PRACTICE; DRUG LABELING; DRUG POTENTIATION; DRUG SAFETY; DRUG USE; HUMAN; INCIDENT REPORT; MEDICAL INFORMATION; MEDICATION ERROR; MEDICATION THERAPY MANAGEMENT; OPIATE ADDICTION; PATIENT INFORMATION; PATIENT SAFETY; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; PRESCRIPTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVIEW; TREATMENT INDICATION;

ANALGESICS, OPIOID; ANESTHESIA; ANESTHESIOLOGY; AUTOMATIC DATA PROCESSING; CRITICAL CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG LABELING; HUMANS; MEDICATION ERRORS; MEDICATION RECONCILIATION; MEDICATION SYSTEMS, HOSPITAL; OPERATING ROOMS; OPIOID-RELATED DISORDERS; PAIN, POSTOPERATIVE;

EID: 84878446462     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-012-9853-y     Document Type: Review

References (55)

1. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004; 170: 1678-86.
2. Committee on Identifying and Preventing Medication Errors; Aspden P, Wolcott J, Bootman JL, Cronenwett LR. Board on Health Care Services. Preventing Medication Errors: Quality Chasm Series. The National Academies Press 2007. Available from URL: http://www.nap.edu/catalog.php?record-id=11623 (accessed November 2012).
3. Pronovost PJ, Miller MR, Wachter RM. Tracking progress in patient safety: an elusive target. JAMA 2006; 296: 696-9.
4. Auerbach AD, Landefeld CS, Shojania KG. The tension between needing to improve care and knowing how to do it. N Engl J Med 2007; 357: 608-13.
5. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29-34.
6. Denham CR. TRUST: The 5 rights of the second victim. J Patient Saf 2007; 3: 107-19.
7. Cooper L, DiGiovanni N, Schultz L, Taylor AM, Nossaman B. Influences observed on incidence and reporting of medication errors in anesthesia. Can J Anesth 2012; 59: 562-70.
8. Webster CS, Merry AF, Larsson L, McGrath KA, Weller J. The frequency and nature of drug administration error during anaesthesia. Anaesth Intensive Care 2001; 29: 494-500.
9. Zhang Y, Dong YJ, Webster CS, et al. The frequency and nature of drug administration error during anaesthesia in a Chinese hospital. Acta Anaesthesiol Scand 2012; DOI: 10.1111/j.1399-6576.2012.02762.x.
10. Fasting S, Gisvold SE. Adverse drug errors in anesthesia, and the impact of coloured syringe labels. Can J Anesth 2000; 47: 1060-7.
11. Sakaguchi Y, Tokuda K, Yamaguchi K, Irita K. Incidence of anesthesia-related medication errors over a 15-year period in a university hospital. Fukuoka Igaku Zasshi 2008; 99: 58-66.
12. Jensen LS, Merry AF, Webster CS, Weller J, Larsson L. Evidence-based strategies for preventing drug administration errors during anaesthesia. Anaesthesia 2004; 59: 493-504.
13. Orser BA, Chen RJ, Yee DA. Medication errors in anesthetic practice: a survey of 687 practitioners. Can J Anaesth 2001; 48: 139-46.
14. Wheeler SJ, Wheeler DW. Medication errors in anaesthesia and critical care. Anaesthesia 2005; 60: 257-73.
15. Currie M, Mackay P, Morgan C, et al. The Australian Incident Monitoring Study. The "wrong drug" problem in anaesthesia: an analysis of 2000 incident reports. Anaesth Intensive Care 1993; 21: 596-601.
16. Orser BA, Oxorn DC. An anaesthetic drug error: minimizing the risk. Can J Anaesth 1994; 41: 120-4.
17. Merry AF, Peck DJ. Anaesthetists, errors in drug administration and the law. N Z Med J 1995; 108: 185-7.
18. Orser BA. Medication safety in anesthetic practice: first do no harm. Can J Anesth 2000; 47: 1051-4.
19. Orser BA, Byrick R. Anesthesia-related medication error: time to take action. Can J Anesth 2004; 51: 756-60.
20. Abeysekera A, Bergman IJ, Kluger MT, Short TG. Drug error in anaesthetic practice: a review of 896 reports from the Australian Incident Monitoring Study database. Anaesthesia 2005; 60: 220-7.
21. Short TG, O'Regan A, Lew J, Oh TE. Critical incident reporting in an anaesthetic department quality assurance programme. Anaesthesia 1993; 48: 3-7.
22. The Institute for Safe Medication Practices Canada. ISMP Canada Safety Bulletin, 2006; 6(2): 2, April 25. Neuromuscular Blocking Agent Labelling and Packaging Initiative. Available from URL: http://www.ismp-canada.org/download/ safetyBulletins/ISMPCSB2006-02PotassiumPhosphates.pdf (accessed November 2012).
23. The Institute for Safe Medication Practices Canada. ISMP Canada Safety Bulletin, 2004; 4: 1-2. "Paralyzing" Mix-Ups in the Operating Room: Opportunity to Improve Safety with Neuromuscular Blockers. Available from http://www.ismp-canada.org/download/safetyBulletins/ISMPCSB2004-07.pdf (accessed November 2012).
24. The Institute for Safe Medication Practices Canada. ISMP Canada Safety Bulletin 2010; 10(3):4, May 25. Neuromuscular Blocking Agents: Another Manufacturer Changes Labelling and Packaging to Increase Safety. Available from URL: http://www.ismp-canada.org/download/safetyBulletins/ISMPCSB2010-03- KnowledgeTranslation.pdf (accessed November 2012).
25. The Institute for Safe Medication Practices Canada. ISMP Canada Safety Bulletin 2011; 11(7):2, November 15. New USP Requirement for Drug Vial Caps and Ferrules. Available from URL: http://www.ismp-canada.org/download/ safetyBulletins/ISMPCSB2011-7-Iodine-Overdose-with-Lugols-Solution.pdf (accessed November 2012).
26. Paoletti RD, Suess TM, Lesko MG, et al. Using bar-code technology and medication observation methodology for safer medication administration. Am J Health Syst Pharm 2007; 64: 536-43.
27. Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med 2010; 362: 1698-707.
28. Morriss FH Jr, Abramowitz PW, Nelson SP, et al. Effectiveness of a barcode medication administration system in reducing preventable adverse drug events in a neonatal intensive care unit: a prospective cohort study. J Pediatr 2009; 154: 363-8.
29. Institute for Safe Medication Practices Canada. Canadian Pharmaceutical Bar Coding Project: Designing a National Strategy for Healthcare. Toronto (ON), ©2000-2012. Available from URL: http://www.ismp-canada.org/barcoding/index. htm (accessed November 2012).
30. Institute for Safe Medication Practices Canada. Canadian Pharmaceutical Bar Coding Project. Joint Technical Statement (version II) on Pharmaceutical Automated Identification and Product Database Requirements. Toronto (ON): 2012. Available from URL: http://www.ismp-canada.org/barcoding/download/JTSv2/JTSv2. pdf (accessed November 2012).
31. Institute for Safe Medication Practices Canada. Supplement A. Canadian Pharmaceutical Bar Coding Project: Guidance for Placement of Bar Codes on Pharmaceutical Labels for Primary Packaging. Toronto (ON): 2012. Available from URL: http://www.ismp-canada.org/barcoding/download/JTSv2/SupplA- LabellingGuidelines.pdf (accessed November 2012).
32. Institute for Safe Medication Practices Canada. Supplement B. Canadian Pharmaceutical Bar Coding Project: Minimum Software Safety Functionality Checklist. From the Joint Technical Statement on Pharmaceutical Automated Identification and Product Database Requirements (Version II). Toronto (ON): 2012. Available from URL: http://www.ismp-canada.org/barcoding/download/JTSv2/ SupplB-MinFunctionality.pdf (accessed November 2012).
33. Merry AF, Webster CS, Hannam J, et al. Multimodal system designed to reduce errors in recording and administration of drugs in anaesthesia: prospective randomized clinical evaluation. BMJ 2011; DOI: 10.1136/bmj.d5543.
34. Fung E. Point-of-care medication bar-coding system in the OR. Pharmacy Practice 2009; (April): 1-6.
35. Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following discharge. Ann Pharmacother 1999; 33: 1147-53.
36. Bell CM, Bajcar J, Bierman AS, Li P, Mamdani MM, Urbach DR. Potentially unintended discontinuation of long-term medication use after elective surgical procedures. Arch Intern Med 2006; 166: 2525-31.
37. Rozich JD, Resar RK. Medication safety: one organization's approach to the challenge. J Clin Outcomes Manage 2001; 8: 27-34.
38. Kwan Y, Fernandes OA, Nagge JJ, et al. Pharmacist medication assessments in a surgical preadmission clinic. Arch Intern Med 2007; 167: 1034-40.
39. Leung V, Mach K, Charlesworth E, Hicks S, Kizemchuk K, Stumpo C. Perioperative Medication Management (POMM) pilot: integrating a community-based medication history (MedsCheck) into medication reconciliation for elective orthopaedic surgery inpatients. Canadian Pharmacists Journal 2010; 143: 82-7.
40. Fernandes OA. Medication reconciliation. Pharmacy Practice 2009; (October): 24-32, 52-5.
41. Schnipper J, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006; 166: 565-71.
42. ISMP Canada. Knowledge is the Best Medicine: iPhone app. Ottawa (ON): Rx&D; 2012. Available from URL: http://www.knowledgeisthebestmedicine.org/ index.php/en/iphone-app (accessed November 2012).
43. Accreditation Canada. How safe are Canadian health organizations? 2011 Report on Required Organizational Practices. Ottawa (ON): 2011. Available from URL: http://www.accreditation.ca/uploadedFiles/News-and-Publications/ Publications/Report-on-ROPs/2011-Report-on-ROPs.pdf (accessed November 2012).
44. Canadian Medication Incident Reporting and Prevention System. Home Page; CMIRPS - SCDPIM; 2011. Available from URL: http://www.cmirps-scdpim.ca/?p=14 (accessed November 2012).
45. Canadian Anesthesiologists' Society. Safety Alerts, 2006-2012. Available from URL: http://www.cas.ca/English/Safety-Alerts (accessed November 2012).
46. Ontario Ministry of Health and Long-Term Care. Excellent Care for All, 2011. Available from URL: http://www.health.gov.on.ca/en/ms/ecfa/public/default. aspx (accessed November 2012).
47. Canadian Centre on Substance Abuse. International Narcotics Control Board 2010. Addressing Prescription Drug Misuse in Canada. National Dialogue Summary Report. Available from URL: http://www.ccsa.ca/2012%20CCSA%20Documents/2012- Prescription-Drug-Misuse-in-Canada%E2%80%93Summary-Report-en.pdf (accessed November 2012).
48. Centers for Disease Control and Prevention. CDC grand rounds: prescription drug overdoses - a U.S. epidemic. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report 2012; 61: 10-3.
49. Gomes T, Mamdami MM, Dhalla I, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011; 171: 686-91.
50. The Institute for Safe Medication Practices Canada. (ISMP Canada Safety Bulletin). 2008; 8(3): 1-2. Drug Interaction Incident with HIV Post-Exposure Prophylaxis. Available from URL: http://www.ismp-canada.org/download/ safetyBulletins/ISMPCSB2008-03HIVPEP.pdf (accessed November 2012).
51. Lange M, Van Aken H, Westphal M, Morelli A. Role of vasopressinergic V1 receptor agonists in the treatment of perioperative catecholamine-refractory arterial hypotension. Best Pract Res Clin Anaesthesiol 2008; 22: 369-81.
52. Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994; 81: 299-307.
53. Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thebert D, Loisance DY. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 2001; 71: 1428-32.
54. Health Canada. Drugs and Health Products. Nov 7, 2012; Health Canada. October 2012. Available from URL: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/ databasdon/dpd-bdpp-data-extract-eng.php and http://www.hc-sc.gc.ca/dhp-mps/ prodnatur/applications/licen-prod/lnhpd-bdpsnh-data-extract-eng.php (accessed November 2012).
55. Hazlet TK, Lee TA, Hansten PD, Horn JR. Performance of community pharmacy drug interaction software. J Am Pharm Assoc 2001; 41: 200-4.